Astera Labs (NASDAQ:ALAB) Shares Down 3.2% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price dropped 3.2% during trading on Wednesday . The stock traded as low as $329.40 and last traded at $330.86. Approximately 5,865,470 shares traded hands during trading, an increase of 5% from the average daily volume of 5,561,926 shares. The stock had previously closed at $341.70.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of recent research reports. Susquehanna increased their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. UBS Group initiated coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Performance

The company has a market cap of $62.93 billion, a price-to-earnings ratio of 248.07, a PEG ratio of 4.38 and a beta of 3.95. The business’s 50 day moving average price is $231.95 and its 200-day moving average price is $177.61.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter last year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the completion of the sale, the director owned 60,134 shares in the company, valued at $21,909,822.90. This trade represents a 5.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company’s stock, valued at $30,075,913.29. This trade represents a 0.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,321,256 shares of company stock worth $480,893,146 over the last ninety days. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently made changes to their positions in ALAB. Atreides Management LP increased its position in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. grew its holdings in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after acquiring an additional 1,693,918 shares during the last quarter. Amundi grew its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC bought a new stake in Astera Labs during the 3rd quarter worth about $209,599,000. Finally, BNP Paribas Financial Markets grew its holdings in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.